In a new study, researchers examined four randomized controlled trials of belimumab (Benlysta®) to gain a better ...

Kezar Life Sciences announced the termination of Phase 2b PALIZADE clinical trial of zetomipzomib, an investigational therapy ...

The Lupus Foundation of America (LFA) is excited to announce Karen Costenbader is the recipient of the LFA’s 2024 Predict and Prevent Lupus Research grant.

Lupus & You is a free educational series where people with lupus and their family and friends can learn more about the latest in lupus research and managing the disease. Here’s a summary of the most ...

This Hispanic Heritage Month, we celebrate the strength, culture, and contribution of the Hispanic and Latino communities across the country. As we celebrate these vibrant communities, it’s also ...

Systemic lupus is the most common form of lupus—it’s what most people mean when they refer to “lupus.” Systemic lupus can be mild or severe. Cutaneous lupus erythematosus This form of lupus is limited ...

Walk to End Lupus Now ™ events provide all people affected by Lupus and their families the opportunity to come together for one unified purpose — to end Lupus. Join the Lupus Foundation of America and ...

The Lupus Foundation of America (LFA) created the Predict and Prevent Lupus Research grant in 2024 to support innovative research aimed at identifying people at high risk for lupus and ultimately ...

Ready to connect with a supportive community? Don't miss out on the Thriving Warriors Lupus Support Group led by dedicated facilitators Carlene Kirkpatrick, Tonya Hinton-Green, and Nikki Santiago. The ...